|
Joshua Philip Prager MD MS is an American physician. Dr. Prager specializes in pain medicine. He is a past president of the North American Neuromodulation Society(NANS).〔(International Neuromodulation Society website )〕〔(Neuromodulation newsletter )〕 and serves as Senior Advisor to the Executive Board of the society. He served two consecutive two year terms as Chair of the Complex Regional Pain Syndrome Group of the International Association for the Study of Pain (IASP).〔(IASP PSNS group )〕 He served on the Board of Directors of the International Neuromodulation Society (INS). He was founder of the Neuromodulation Therapy Access Coalition (NTAC), a coalition of national and international physician organizations and other stakeholders dedicated to insuring patient access to neuromodulation. He serves as Liaison Board Member between NANS and the INS. ==Life and research== After undergraduate and graduate studies in Stony Brook University, and Harvard where he served as the President of the Harvard Graduate Student Council, Dr. Prager graduated from Stanford University with M.D. as well as M.S. in Management/Health Services Research in 1981. He completed training in internal medicine at UCLA before completing training in anesthesiology at Massachusetts General Hospital (MGH) at Harvard Medical School and Stanford University School of Medicine. He has served on the full-time faculty at MGH at Harvard Medical School and at UCLA School of Medicine where he served as Director of the UCLA Pain Medicine Center. He is Board Certified in Internal Medicine, Anesthesiology and Pain Medicine. Dr. Prager has authored numerous scientific publications and book chapters in pain management, especially on complex regional pain syndrome (CRPS), intrathecal pumps, and spinal cord stimulators. He directs a comprehensive interdisciplinary rehabilitation program for treatment of CRPS, integrating physical therapy, behavioral treatment, neuromodulation, ketamine infusions, and occasionally hyperbaric oxygen therapy. For ten years Dr. Prager has been administering ketamine infusions for treatment of complex regional pain syndrome (CRPS), neuropathic pain, other pain syndromes, as well as depression . He recently published two reviews on the use of ketamine in peer reviewed journals. He is currently researching functional MRI (fMRI) changes as a result of ketamine treatment, and managing side effects of ketamine infusions. ==Current position== Dr. Prager is the current director of California Pain Medicine Center and Center for Rehabilitation of Pain Syndromes at UCLA and is also the Editor of the California Society of Anesthesiologists Pain and End-of-Life CME Program.〔(California Society of Anesthesiologists CME )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Joshua Prager (doctor)」の詳細全文を読む スポンサード リンク
|